B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.061 DKK 38.01%
Market Cap: 13m DKK
Have any thoughts about
Brain+ A/S?
Write Note

Brain+ A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brain+ A/S
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Brain+ A/S
CSE:BRAINP
Revenue
kr2.4m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NNIT A/S
CSE:NNIT
Revenue
kr1.7B
CAGR 3-Years
-15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
M
Monsenso A/S
CSE:MONSO
Revenue
kr9.6m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Brain+ A/S
Glance View

Market Cap
13m DKK
Industry
Health Care

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.

BRAINP Intrinsic Value
0.041 DKK
Overvaluation 32%
Intrinsic Value
Price
B

See Also

What is Brain+ A/S's Revenue?
Revenue
2.4m DKK

Based on the financial report for Dec 31, 2023, Brain+ A/S's Revenue amounts to 2.4m DKK.

What is Brain+ A/S's Revenue growth rate?
Revenue CAGR 3Y
-29%

Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for Brain+ A/S have been -29% over the past three years .

Back to Top